Terns Pharmaceuticals, Inc. TERN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

46/100

3/6 Pass

SharesGrow Intrinsic Value

Terns Pharmaceuticals, Inc. (TERN) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es Vivo Capital Surplus Fund VIII, L.P. con 3,581,592 acciones. Otros tenedores destacados incluyen ORBIMED ADVISORS LLC y GORDON CARL L.

En los últimos 12 meses, los internos han realizado 29 transacciones en TERN acciones — 20 compras (valoradas en $1.75M) y 8 ventas (valoradas en $1.11M). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.

TERN Participación de Insiders

Principal Titular

Vivo Capital Surplus Fund VIII, L.P.

3,581,592 acciones

Compras (12 meses)

$1.75M valor

Ventas (12 meses)

$1.11M valor

Actividad de Transacciones (12 meses)

Comprar 69%

Vender 28%

Principales Titulares Internos

#	Nombre	Cargo	Acciones en Propiedad	Última Declaración	Tamaño Relativo
1	Vivo Capital Surplus Fund Viii, L.p.	Director	3,581,592	2022-09-08	100%
2	Orbimed Advisors Llc	10 Percent Owner	756,258	2024-07-17	21%
3	Gordon Carl L	10 Percent Owner	756,258	2024-07-17	21%
4	Aden Matthew J	SVP Worldwide Sales	500,000	2005-08-02	14%
5	Lav Biosciences Fund V, L.p.	Director	405,583	2022-11-28	11%
6	Burroughs Amy L.	Chief Executive Officer	288,976	2026-03-17	8%
7	Vivo Opportunity, Llc	10 Percent Owner	275,772	2024-04-03	8%
8	Russell Kerry Strong	Chief Medical Officer	240,000	2022-07-06	7%
9	Chase Jerry D	Chief Executive Officer	239,520	2004-09-10	7%
10	Taylor Arthur T	SVP, CFO	125,000	2003-05-30	3%
11	Kuriakose Emil	Chief Medical Officer	105,673	2026-04-02	3%
12	Gengos Andrew	Chief Financial Officer	101,788	2026-01-16	3%
13	Yoon Seokho Bryan	COO and General Counsel	91,940	2024-06-04	3%
14	Vignola Mark J.	Chief Financial Officer	83,811	2025-01-06	2%
15	Quirk Erin	President, Head of R&d	75,000	2024-01-25	2%
16	Lu Hongbo	Director	45,000	2025-06-12	1%
17	Orbimed Genesis Gp Llc	Director	38,450	2022-08-18	1%
18	Sundaram Senthil Vel	Chief Executive Officer	9,770	2023-06-02	0%
19	Taylor Ann Elizabeth	Director	4,676	2024-07-02	0%
20	Solomon Lewis	Director	3,000	2005-02-18	0%

Transacciones Recientes (últimos 12 meses)

Fecha	Nombre	Cargo	Tipo	Acciones	Precio	Valor
2026-04-01	Kuriakose Emil	Chief Medical Officer	Venta Informativa	942	$52.75	$49.69K
2026-03-16	Burroughs Amy L.	Chief Executive Officer	Venta Informativa	2,770	$47.30	$131.03K
2026-02-17	Burroughs Amy L.	Chief Executive Officer	Venta Informativa	4,083	$39.80	$162.5K
2026-02-01	Quigley Jill M.	Director	Concesión de RSU	1,697	$34.60	$58.72K
2026-02-01	Tripuraneni Radhika	Director	Concesión de RSU	1,697	$34.60	$58.72K
2026-02-01	Azelby Robert	Director	Concesión de RSU	1,697	$34.60	$58.72K
2026-02-01	Turner Heather D	Director	Concesión de RSU	1,697	$34.60	$58.72K
2026-02-01	Kindler Jeffrey B	Director	Concesión de RSU	1,697	$34.60	$58.72K
2026-02-01	Fellows David A	Director	Concesión de RSU	2,828	$34.60	$97.85K
2026-01-14	Kuriakose Emil	Chief Medical Officer	Concesión de RSU	56,250	-	-
2026-01-15	Burroughs Amy L.	Chief Executive Officer	Venta Informativa	7,521	$37.53	$282.23K
2026-01-14	Burroughs Amy L.	Chief Executive Officer	Concesión de RSU	150,000	-	-
2026-01-14	Gengos Andrew	Chief Financial Officer	Concesión de RSU	68,750	-	-
2026-01-02	Kuriakose Emil	Chief Medical Officer	Venta Informativa	955	$38.36	$36.63K
2026-01-05	Burroughs Amy L.	Chief Executive Officer	Ejercicio de Opciones (Venta)	150,000	-	-
2026-01-02	Burroughs Amy L.	Chief Executive Officer	Ejercicio de Opciones	21,551	$4.64	$100K
2025-11-04	Quigley Jill M.	Director	Venta Informativa	24,520	$18.00	$441.36K
2025-10-01	Kuriakose Emil	Chief Medical Officer	Venta Informativa	944	$7.85	$7.41K
2025-07-01	Kuriakose Emil	Chief Medical Officer	Venta Informativa	853	$4.27	$3.64K
2025-06-27	Gengos Andrew	Chief Financial Officer	Compra Informativa	5,000	$3.93	$19.63K
2025-06-25	Burroughs Amy L.	Chief Executive Officer	Compra Informativa	23,314	$3.87	$90.23K
2025-06-16	Gengos Andrew	Chief Financial Officer	Compra Informativa	5,000	$3.95	$19.73K
2025-06-13	Gengos Andrew	Chief Financial Officer	Compra Informativa	5,000	$3.75	$18.75K
2025-06-11	Quigley Jill M.	Director	Concesión de RSU	45,000	$4.10	$184.5K
2025-06-11	Lu Hongbo	Director	Concesión de RSU	45,000	$4.10	$184.5K